| Code |
Title |
|
–
|
Top Categories
|
|
3 |
Administration
|
|
3E |
Physiological Systems and Anatomical Regions
|
|
3E0
|
Introduction
Administration, Physiological Systems and Anatomical Regions, Introduction
|
|
3E0F |
Respiratory Tract
|
|
3E0F3 |
Percutaneous
|
|
3E0F30 |
Antineoplastic
|
|
3E0F304
|
Liquid Brachytherapy Radioisotope
Introduction of Liquid Brachytherapy Radioisotope into Respiratory Tract, Percutaneous Approach
|
|
3E0F305
|
Other Antineoplastic
Introduction of Other Antineoplastic into Respiratory Tract, Percutaneous Approach
|
|
3E0F30M
|
Monoclonal Antibody
Introduction of Antineoplastic, Monoclonal Antibody, into Respiratory Tract, Percutaneous Approach
|
|
3E0F32 |
Anti-infective
|
|
3E0F328
|
Oxazolidinones
Introduction of Oxazolidinones into Respiratory Tract, Percutaneous Approach
|
|
3E0F329
|
Other Anti-infective
Introduction of Other Anti-infective into Respiratory Tract, Percutaneous Approach
|
|
3E0F33 |
Anti-inflammatory
|
|
3E0F33Z
|
No Qualifier
Introduction of Anti-inflammatory into Respiratory Tract, Percutaneous Approach
|
|
3E0F36 |
Nutritional Substance
|
|
3E0F36Z
|
No Qualifier
Introduction of Nutritional Substance into Respiratory Tract, Percutaneous Approach
|
|
3E0F37 |
Electrolytic and Water Balance Substance
|
|
3E0F37Z
|
No Qualifier
Introduction of Electrolytic and Water Balance Substance into Respiratory Tract, Percutaneous Approach
|
|
3E0F3B |
Anesthetic Agent
|
|
3E0F3BZ
|
No Qualifier
Introduction of Anesthetic Agent into Respiratory Tract, Percutaneous Approach
|
|
3E0F3G |
Other Therapeutic Substance
|
|
3E0F3GC
|
Other Substance
Introduction of Other Therapeutic Substance into Respiratory Tract, Percutaneous Approach
|
|
3E0F3H |
Radioactive Substance
|
|
3E0F3HZ
|
No Qualifier
Introduction of Radioactive Substance into Respiratory Tract, Percutaneous Approach
|
|
3E0F3K |
Other Diagnostic Substance
|
|
3E0F3KZ
|
No Qualifier
Introduction of Other Diagnostic Substance into Respiratory Tract, Percutaneous Approach
|
|
3E0F3N |
Analgesics, Hypnotics, Sedatives
|
|
3E0F3NZ
|
No Qualifier
Introduction of Analgesics, Hypnotics, Sedatives into Respiratory Tract, Percutaneous Approach
|
|
3E0F3S |
Gas
|
|
3E0F3SD
|
Nitric Oxide
Introduction of Nitric Oxide Gas into Respiratory Tract, Percutaneous Approach
|
|
3E0F3SF
|
Other Gas
Introduction of Other Gas into Respiratory Tract, Percutaneous Approach
|
|
3E0F3T |
Destructive Agent
|
|
3E0F3TZ
|
No Qualifier
Introduction of Destructive Agent into Respiratory Tract, Percutaneous Approach
|
|
3E0F4 |
Percutaneous Endoscopic
|
|
3E0F4G |
Other Therapeutic Substance
|
|
3E0F4GC
|
Other Substance
Introduction of Other Therapeutic Substance into Respiratory Tract, Percutaneous Endoscopic Approach
|
|
3E0F7 |
Via Natural or Artificial Opening
|
|
3E0F70 |
Antineoplastic
|
|
3E0F704
|
Liquid Brachytherapy Radioisotope
Introduction of Liquid Brachytherapy Radioisotope into Respiratory Tract, Via Natural or Artificial Opening
|
|
3E0F705
|
Other Antineoplastic
Introduction of Other Antineoplastic into Respiratory Tract, Via Natural or Artificial Opening
|
|
3E0F70M
|
Monoclonal Antibody
Introduction of Antineoplastic, Monoclonal Antibody, into Respiratory Tract, Via Natural or Artificial Opening
|
|
3E0F72 |
Anti-infective
|
|
3E0F728
|
Oxazolidinones
Introduction of Oxazolidinones into Respiratory Tract, Via Natural or Artificial Opening
|
|
3E0F729
|
Other Anti-infective
Introduction of Other Anti-infective into Respiratory Tract, Via Natural or Artificial Opening
|
|
3E0F73 |
Anti-inflammatory
|
|
3E0F73Z
|
No Qualifier
Introduction of Anti-inflammatory into Respiratory Tract, Via Natural or Artificial Opening
|
|
3E0F76 |
Nutritional Substance
|
|
3E0F76Z
|
No Qualifier
Introduction of Nutritional Substance into Respiratory Tract, Via Natural or Artificial Opening
|
|
3E0F77 |
Electrolytic and Water Balance Substance
|
|
3E0F77Z
|
No Qualifier
Introduction of Electrolytic and Water Balance Substance into Respiratory Tract, Via Natural or Artificial Opening
|
|
3E0F7B |
Anesthetic Agent
|
|
3E0F7BZ
|
No Qualifier
Introduction of Anesthetic Agent into Respiratory Tract, Via Natural or Artificial Opening
|
|
3E0F7G |
Other Therapeutic Substance
|
|
3E0F7GC
|
Other Substance
Introduction of Other Therapeutic Substance into Respiratory Tract, Via Natural or Artificial Opening
|
|
3E0F7H |
Radioactive Substance
|
|
3E0F7HZ
|
No Qualifier
Introduction of Radioactive Substance into Respiratory Tract, Via Natural or Artificial Opening
|
|
3E0F7K |
Other Diagnostic Substance
|
|
3E0F7KZ
|
No Qualifier
Introduction of Other Diagnostic Substance into Respiratory Tract, Via Natural or Artificial Opening
|
|
3E0F7N |
Analgesics, Hypnotics, Sedatives
|
|
3E0F7NZ
|
No Qualifier
Introduction of Analgesics, Hypnotics, Sedatives into Respiratory Tract, Via Natural or Artificial Opening
|
|
3E0F7S |
Gas
|
|
3E0F7SD
|
Nitric Oxide
Introduction of Nitric Oxide Gas into Respiratory Tract, Via Natural or Artificial Opening
|
|
3E0F7SF
|
Other Gas
Introduction of Other Gas into Respiratory Tract, Via Natural or Artificial Opening
|
|
3E0F7T |
Destructive Agent
|
|
3E0F7TZ
|
No Qualifier
Introduction of Destructive Agent into Respiratory Tract, Via Natural or Artificial Opening
|
|
3E0F8 |
Via Natural or Artificial Opening Endoscopic
|
|
3E0F80 |
Antineoplastic
|
|
3E0F804
|
Liquid Brachytherapy Radioisotope
Introduction of Liquid Brachytherapy Radioisotope into Respiratory Tract, Via Natural or Artificial Opening Endoscopic
|
|
3E0F805
|
Other Antineoplastic
Introduction of Other Antineoplastic into Respiratory Tract, Via Natural or Artificial Opening Endoscopic
|
|
3E0F80M
|
Monoclonal Antibody
Introduction of Antineoplastic, Monoclonal Antibody, into Respiratory Tract, Via Natural or Artificial Opening Endoscopic
|
|
3E0F82 |
Anti-infective
|
|
3E0F828
|
Oxazolidinones
Introduction of Oxazolidinones into Respiratory Tract, Via Natural or Artificial Opening Endoscopic
|
|
3E0F829
|
Other Anti-infective
Introduction of Other Anti-infective into Respiratory Tract, Via Natural or Artificial Opening Endoscopic
|
|
3E0F83 |
Anti-inflammatory
|
|
3E0F83Z
|
No Qualifier
Introduction of Anti-inflammatory into Respiratory Tract, Via Natural or Artificial Opening Endoscopic
|
|
3E0F86 |
Nutritional Substance
|
|
3E0F86Z
|
No Qualifier
Introduction of Nutritional Substance into Respiratory Tract, Via Natural or Artificial Opening Endoscopic
|
|
3E0F87 |
Electrolytic and Water Balance Substance
|
|
3E0F87Z
|
No Qualifier
Introduction of Electrolytic and Water Balance Substance into Respiratory Tract, Via Natural or Artificial Opening Endoscopic
|
|
3E0F8B |
Anesthetic Agent
|
|
3E0F8BZ
|
No Qualifier
Introduction of Anesthetic Agent into Respiratory Tract, Via Natural or Artificial Opening Endoscopic
|
|
3E0F8G |
Other Therapeutic Substance
|
|
3E0F8GC
|
Other Substance
Introduction of Other Therapeutic Substance into Respiratory Tract, Via Natural or Artificial Opening Endoscopic
|
|
3E0F8H |
Radioactive Substance
|
|
3E0F8HZ
|
No Qualifier
Introduction of Radioactive Substance into Respiratory Tract, Via Natural or Artificial Opening Endoscopic
|
|
3E0F8K |
Other Diagnostic Substance
|
|
3E0F8KZ
|
No Qualifier
Introduction of Other Diagnostic Substance into Respiratory Tract, Via Natural or Artificial Opening Endoscopic
|
|
3E0F8N |
Analgesics, Hypnotics, Sedatives
|
|
3E0F8NZ
|
No Qualifier
Introduction of Analgesics, Hypnotics, Sedatives into Respiratory Tract, Via Natural or Artificial Opening Endoscopic
|
|
3E0F8S |
Gas
|
|
3E0F8SD
|
Nitric Oxide
Introduction of Nitric Oxide Gas into Respiratory Tract, Via Natural or Artificial Opening Endoscopic
|
|
3E0F8SF
|
Other Gas
Introduction of Other Gas into Respiratory Tract, Via Natural or Artificial Opening Endoscopic
|
|
3E0F8T |
Destructive Agent
|
|
3E0F8TZ
|
No Qualifier
Introduction of Destructive Agent into Respiratory Tract, Via Natural or Artificial Opening Endoscopic
|